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Luís Pinho13, Sebastian Smulski14, Karlien Supré15, Jantijn M. Swinkels16, Mark A. Holmes17, 
Theo J. G. M. Lam1,18 & Gerrit Koop1
Intramammary infections (IMI) with Staphylococcus aureus are a common cause of bovine mastitis and 
can result in both clinical (CM) or subclinical mastitis (SCM). Although bacterial isolates of S. aureus 
differ in their virulence potential it is largely unclear which bacterial virulence factors are responsible 
for increased clinical severity. We performed a genome wide association study and used a generalized 
linear mixed model to investigate the correlation between gene carriage, lineage and clinical outcome 
of IMI in a collection of S. aureus isolates from cattle with CM (n = 125) and SCM (n = 151) from 11 
European countries. An additional aim was to describe the genetic variation of bovine S. aureus 
in Europa. The dominant lineages in our collection were clonal complex (CC) 151 (81/276, 29.3%), 
CC97 (54/276, 19.6%), CC479 (32/276, 11.6%) and CC398 (19/276, 6.9%). Virulence and antimicrobial 
resistance (AMR) gene carriage was highly associated with CC. Among a selection of nine virulence 
and AMR genes, CC151, CC479 and CC133 carried more virulence genes than other CCs, and CC398 
was associated with AMR gene carriage. Whereas CC151, CC97 were widespread in Europe, CC479, 
CC398 and CC8 were only found in specific countries. Compared to CC151, CC479 was associated with 
CM rather than SCM (OR 3.62; 95% CI 1.38–9.50) and the other CCs were not. Multiple genes were 
associated with CM, but due to the clustering within CC of carriage of these genes, it was not possible 
to differentiate between the effect of gene carriage and CC on clinical outcome of IMI. Nevertheless, 
this study demonstrates that characterization of S. aureus CC and virulence genes helps to predict 
the likelihood of the occurrence of CM following S. aureus IMI and highlights the potential benefit of 
diagnostics tools to identify S. aureus CC during bovine mastitis.
Mastitis is responsible for significant financial losses on dairy farms due to reduced milk yield, milk unsuitable 
for consumption, treatment costs and culling of  animals1,2. The main causes of bovine mastitis are bacterial 
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intramammary infections (IMI), with Staphylococcus aureus being one of the most relevant  pathogens3. Infec-
tions with S. aureus mostly result in subclinical mastitis (SCM), but can also lead to clinical mastitis (CM)4.
The S. aureus clones responsible for bovine mastitis predominantly belong to bovine-associated clonal com-
plexes (CC), such as CC151, CC97, CC133, CC479 and  CC7715,6. The genomic content of S. aureus clones can 
differ greatly due to their accessory genome, which makes up approximately 25% of the total  genome7. The acces-
sory genome of S. aureus predominantly consists of genes introduced by horizontal gene transfer (HGT), with 
these transferred genes often being phage genes, virulence and antimicrobial resistance (AMR) genes, expected 
to affect the pathogenesis of S. aureus  IMI8. A large number of virulence genes have been identified in S. aureus 
isolates obtained from bovine mastitis cases, several of which are involved in evasion of the host immune response 
during  infection8,9. Leukocidins, such as LukMF’, can directly attack immune cells in the lumen of the mammary 
gland and superantigens (SAs), such as enterotoxins seA–seQ, or toxic shock syndrome toxin 1 (tsst-1), massively 
activate T lymphocytes and antigen-presenting cells, interfering with the buildup of a proper adaptive immune 
 response10. Furthermore, Staphylococcal superantigen-like proteins (SSLs) disrupt different pathways of the 
immune response, such as pathogen recognition by TLR-2 (SSL-3, SSL-4), neutrophil function and recruitment 
(SSL-1, SSL-5, SLL-7, SSL-13) and the opsonization of bacteria (SSL-7)10,11. Some of these immune evasion factors 
are considered ruminant  adapted10, such as LukMF’ and the S. aureus pathogenicity island encoded variant of the 
Von Willebrand factor‐binding protein (SaPI vWFbp)12,13. Furthermore, S. aureus can carry AMR encoding genes, 
including blaZ, tetM and mecA, which reduce effectiveness of antimicrobial treatment of S. aureus  mastitis14. 
The majority of virulence and AMR genes are located on mobile genetic elements and S. aureus belonging to 
the same CC have specific virulence gene signatures due to clonal  expansion6,15,16 and restriction-modification 
systems that reduce HGT between different S. aureus  lineages17,18.
Several studies investigated CCs and virulence/AMR gene carriage among bovine S. aureus isolates responsi-
ble for  IMI6,9,19, but only few directly compare isolates from CM and SCM cases. Recently, we identified a specific 
bovine S. aureus lineage (CC479) that was associated with CM in The  Netherlands20. In addition, carriage of 
certain genes (lukM-lukF′, seO) was overrepresented among CM isolates compared to SCM  isolates21,22. This 
suggests that some S. aureus lineages are more likely to cause CM than others. Although both CM and SCM 
lead to financial losses for the farm and are associated with animal disease and welfare, the costs of treatment of 
CM are substantially higher than of  SCM1,23. Also, the effect of CM on animal welfare obviously is considerable 
larger than for  SCM24. Therefore, identification of S. aureus isolates with increased risk of developing into CM is 
likely valuable to better support farm health management decisions. However, studies comparing isolates from 
CM and SCM have been mainly on a national  scale20–22, whereas the genetic makeup of bovine S. aureus likely 
differs between countries. Therefore, in this study we performed whole-genome sequencing (WGS) of 276 S. 
aureus isolates from cattle with CM or SCM in 11 European countries.
The primary aim of this study was to investigate differences in lineage and genomic content between S. aureus 
isolates responsible for CM and SCM. A second aim was to describe the variation in lineages, virulence gene and 
AMR gene carriage of bovine S. aureus isolates in Europe.
Results
Bovine S. aureus CCs differ in their carriage of immune evasion and AMR genes. After selection 
of isolates and quality control of WGS results, 276 genomes were available of S. aureus isolates obtained from 
bovine mastitis cases originating from 254 unique herds in eleven different European countries. There was an 
approximately even distribution of CM (125/276, 45%) and SCM (151/276, 55%) isolates, and S. aureus in the 
collection belonged to eighteen different CCs. The most prevalent CCs were CC151 (81/276, 29.3%), CC97 
(54/276, 19.6%), CC479 (32/276, 11.6%), CC133 (25/276, 9.1%), CC398 (19/276, 6.9%), CC1 (14/276, 5.1%), 
CC20 (11/276, 4.0%) and CC8 (11/276, 4.0%), and carriage of a selection of nine key virulence and AMR genes 
among isolates was related to CC (Table 1). The CC151, CC479 and CC133 strains had high carriage of viru-
lence genes but lacked AMR genes. All these three CCs carried the lukM-lukF′ genes and CC479, CC151 also 
possessed SA genes. In addition, CC479, CC133 S. aureus carried the SaPI encoded vWFbp gene (Table 1). In 
contrast, CC398 S. aureus lacked all these virulence factors but did have a high carriage rate of the AMR genes 
blaZ (8/19, 42%), tetM (19/19, 100%) and mecA (11/19, 58%) (Table 1). The CC97 displayed a moderate carriage 
of both virulence gene lukM-lukF’ (16/54, 30%) and the AMR gene blaZ (16/54, 30%) (Table 1).
Heatmaps of the BLAST score ratio (BSR)25 of all S. aureus genes annotated as (putative) SAs or SSLs by 
prokka26 demonstrated that bovine S. aureus CCs differ in their carriage of these immune evasion factors (Sup-
plementary Figs. S1, S2). Notable differences in SA carriage were the high number of SAs (up to 12 different 
SAs) genes carried by CC151, whereas CC398 isolates lacked SAs. Although most SSLs were detected in all S. 
aureus, the BSR of these SSLs differed between S. aureus CCs. However, the SSL-7, SSL-8, SSL-9 genes were only 
absent in CC479 S. aureus. Furthermore, two genes that were annotated as unnamed SSLs (GenBank references: 
WP_143564871.1 and WP_124375191) were exclusively found among CC97 isolates (Supplementary Fig. S2).
To screen for target genes that could differentiate between major ruminant CCs in a PCR-based assay, the 
presence of potential CC exclusive genes was also investigated (Supplementary Fig. S3, Supplementary Table S1). 
The highest number of CC-exclusive genes were found for CC479 (n = 17), followed by CC20 (n = 4), CC151 
(n = 3), CC8 (n = 2) and CC133 (n = 2). For CC97, CC398, only a single unique gene was identified and no CC 
exclusive genes were found for CC1 isolates.
Heterogeneous spatial distribution of CCs across Europe. There was a significant difference in the 
distribution of S. aureus CCs between different countries (Fisher’s Exact Test, p < 0.001). Whereas CC151 (10 out 
11 countries) and CC97 (9 out 11) S. aureus were detected in almost all countries, CC398 (6 out 11) and CC479 
(5 out 11) were considerably less widespread in our collection (Table 2). The CC398 lineage was predominantly 
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Table 1.  Number and percentage of isolates positive for a selection of virulence and antimicrobial resistance 
genes per clonal complex and number and proportion of clinical mastitis of 276 S. aureus isolates obtained 
from bovine clinical and subclinical mastitis in 11 European countries. a Clonal complex. b Carriage of genes 
determined using pangenome data from roary. c Number and percentage of clinical mastitis cases per CC. 
d Cluster-specific odds ratio of the isolate being cultured from CM versus SCM from a generalized linear mixed 
model with country as a random effect. e Reference class for variable CC within the generalized linear mixed 
model. f Only CCs with n > 10 were included in model. g Significance of class within the variable CC.
CCa n %
Virulence genes n (%)
Antimicrobial resistance genes 
n (%) Manifestation of mastitis
lukM-
lukF′b scn
SaPI 
vWFbp seI seL tsst-1 blaZ tetM mecA CMc
Odds  ratiod (95% 
CI) Pg
151 81 29.3 81 (100) 0 (0) 0 (0) 80 (99) 19 (23) 19 (23) 1 (1) 0 (0) 0 (0) 41 (51) Refe Ref
97 54 19.6 16 (30) 7 (13) 0 (0) 0 (0) 0 (0) 0 (0) 16 (30) 0 (0) 0 (0) 23 (42) 0.75 (0.37–1.54) 0.44
479 32 11.6 30 (94) 0 (0) 32 (100) 32 (100) 0 (0) 0 (0) 0 (0) 1 (3) 0 (0) 25 (78) 3.62 (1.38–9.50) < 0.01
133 25 9.1 23 (92) 21 (84) 25 (100) 0 (0) 2 (8) 2 (8) 0 (0) 0 (0) 0 (0) 13 (52) 1.05 (0.42–2.61) 0.92
398 19 6.9 0 (0) 10 (52) 0 (0) 0 (0) 0 (0) 0 (0) 8 (42) 19 (100) 11 (58) 5 (27) 0.41 (0.12–1.48) 0.17
1 14 5.1 9 (64) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 3 (21) 0.30 (0.07–1.23 0.10
20 11 4.0 0 (0) 0 (0) 0 (0) 7 (64) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0.34 (0.08–1.45) 0.15
8 11 4.0 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 6 (54) 0 (0) 0 (0) 2 (18) 0.21 (0.43–1.10) 0.06
9 5 1.8 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 4 (66) 0 (0) 0 (0) 2 (33) NAf NA
50 5 1.8 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (20) 0 (0) 0 (0) 1 (20) NA NA
49 4 1.4 1 (25) 0 (0) 0 (0) 0 (0) 1 (25) 0 (0) 1 (25) 0 (0) 0 (0) 1 (25) NA NA
7 4 1.4 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (50) NA NA
5 4 1.4 0 (0) 0 (0) 0 (0) 4 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 3 (75) NA NA
45 3 1.1 0 (0) 0 (0) 0 (0) 1 (33) 1 (25) 0 (0) 1 (33) 0 (0) 0 (0) 0 (0) NA NA
101 1 0.4 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) NA NA
22 1 0.4 0 (0) 0 (0) 0 (0) 1 (100) 0 (0) 0 (0) 1 (100) 0 (0) 0 (0) 0 (0) NA NA
30 1 0.4 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (100) 0 (0) 0 (0) 0 (0) NA NA
425 1 0.4 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (100) NA NA
Total 276 160 (58) 38 (14) 57 (21) 125 (45) 24 (9) 21 (8) 40 (15) 20 (7) 11 (4) 125 (45)
Table 2.  Number and percentage of bovine S. aureus of 276 S. aureus isolates per clonal complex ranked 
per country or contributing region obtained from bovine clinical and subclinical mastitis in 11 European 
countries. a Clonal complex. b Lower Saxony region in Germany. c Bavaria region in Germany.
CCa N (%)
Be
n (%)
Dk
n (%)
Fr
n (%)
Ge  (Lsb)
n (%)
Ge  (Byc)
n (%)
Hu
n (%)
It
n (%)
NL
n (%)
Po
n (%)
Pt
n (%)
Es
n (%)
Uk
n (%)
151 81 (29) 13 (43) 5 (31) 4 (17) 10 (34) 8 (27) 3 (16) 6 (20) 14 (64) 0 (0) 2 (29) 2 (17) 14 (52)
97 54 (20) 4 (13) 1 (6) 7 (30) 4 (14) 6 (20) 7 (37) 9 (30) 0 (0) 5 (16) 0 (0) 2 (17) 9 (33)
479 32 (12) 8 (27) 0 (0) 0 (0) 2 (7) 8 (27) 0 (0) 3 (10) 8 (36) 0 (0) 3 (43) 0 (0) 0 (0)
133 25 (9) 4 (13) 4 (25) 2 (9) 7 (24) 2 (7) 0 (0) 2 (7) 0 (0) 1 (3) 0 (0) 3 (25) 0 (0)
398 19 (7) 0 (0) 0 (0) 1 (4) 2 (7) 0 (0) 1 (5) 1 (3) 0 (0) 10 (32) 0 (0) 4 (33) 0 (0)
1 14 (5) 1 (3) 0 (0) 1 (4) 0 (0) 0 (0) 2 (11) 1 (3) 0 (0) 7 (23) 0 (0) 0 (0) 2 (7)
20 11 (4) 0 (0) 0 (0) 4 (17) 1 (3) 0 (0) 5 (26) 0 (0) 0 (0) 0 (0) 0 (0) 1 (8) 0 (0)
8 11 (4) 0 (0) 0 (0) 0 (0) 0 (0) 5 (17) 0 (0) 6 (20) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
9 5 (2) 0 (0) 1 (6) 0 (0) 0 (0) 0 (0) 0 (0) 1 (3) 0 (0) 1 (3) 2 (29) 0 (0) 0 (0)
50 5 (2) 0 (0) 5 (31) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
5 4 (1) 0 (0) 0 (0) 2 (9) 0 (0) 0 (0) 0 (0) 1 (3) 0 (0) 0 (0) 0 (0) 0 (0) 1 (4)
49 4 (1) 0 (0) 0 (0) 1 (4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 3 (10) 0 (0) 0 (0) 0 (0)
7 4 (1) 0 (0) 0 (0) 0 (0) 3 (10) 0 (0) 1 (5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
45 3 (1) 0 (0) 0 (0) 1 (4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (6) 0 (0) 0 (0) 0 (0)
101 1 (0.5) 0 (0) 0 (0) 0 (0) 0 (0) 1 (3) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
22 1 (0.5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (3) 0 (0) 0 (0) 0 (0)
30 1 (0.5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (3) 0 (0) 0 (0) 0 (0)
425 1 (0.5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (4)
Total 276 30 16 24 29 30 19 30 22 31 7 12 27
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found in isolates from Poland and Spain. Isolates belonging to CC8 originated exclusively from either Italy or 
Bavaria region in Germany. Also, all CC50 isolates originated from Denmark (Table 2).
Pangenome of bovine S. aureus and phylogenetic analysis. To investigate the phylogeny of our 
bovine S. aureus isolates, the pangenome of the entire collection was determined (n = 5720 genes) and a phylo-
genetic tree was constructed based on a super-alignment of the 1953 genes in the core genome (genes present 
in > 99% of isolates) (Fig. 1). A second phylogenetic tree was built based on the binary presence or absence of 
genes in the accessory genome (Fig. 2). Within both phylogenetic trees, isolates clustered within CC and two 
Figure 1.  Maximum-likelihood phylogenetic tree based on the alignment of core genome (genes n = 1953) 
performed using roary v3.1239 and MAFFT of 276 S. aureus isolates obtained from bovine clinical and 
subclinical mastitis cases from 11 European countries. Dark and light grey shading displays Clonal Complex 
(CC), the outer ring represents the country of origin and the inner ring the clinical versus subclinical mastitis of 
each isolate. The phylogenetic tree was rooted with the CC22 clade and visualized using iTOL v3.641.
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major clusters of CCs could be identified. The largest cluster, labeled as cluster A consisted of CC151, CC479, 
CC133, CC425, CC49 and CC50 isolates and second largest cluster B included CC97, CC8, CC1, CC20, CC9, 
CC7, CC5, CC30 and CC101. (Figs.  1, 2). There was uneven distribution of CM and SCM isolates between 
clusters, with more CM isolates being present in Cluster A (81/148, 55%) compared to cluster B (38/103, 36%) 
(Pearson’s Chi-squared test p < 0.01).
In general, the phylogenetic tree based on the core genome was similar to the tree based on the accessory 
genome. In addition, the phylogenetic tree shows considerable variation in accessory gene content, most notably 
within CC151 and CC97, but almost no variation in accessory gene carriage was observed among CC479 and 
CC133 S. aureus isolates (Fig. 2).
Staphylococcus aureus CC479 is associated with CM. In order to further study the association 
between S. aureus CC and clinical outcome of IMI, a generalised linear mixed model (GLMM) was built with 
CM versus SCM as the outcome variable, CC as predictor variable and the country of orgin of isolates as a ran-
dom effect. For this model, isolates belonging to CCs with n < 10 (CC9, CC50, CC49, CC7, CC45, CC5, CC101, 
CC22, CC30, and CC425) were clustered together in a single category labeled as ‘other’. Including CC improved 
the fit over the model compared to the model with only random effects (ANOVA, p = 0.003) and isolates belong-
ing to CC479 were more likely to originate from CM than from SCM (OR 3.62; 95% CI 1.38–9.50, p < 0.01) 
Figure 2.  Maximum-likelihood phylogenetic tree based on presence or absence of genes of the accessory 
genome (n = 2023 genes) of 276 S. aureus isolates obtained from bovine clinical or subclinical mastitis from 11 
European countries. Dark and light grey shading displays Clonal Complex (CC). The phylogenetic tree was 
rooted with the CC22 clade and visualized using iTOL v3.641.
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compared to the reference category (CC151). In addition, there was a trend for CC8 (OR 0.22; 95% CI 0.04–1.1; 
p = 0.06) and CC1 (OR 0.30; 95% CI 0.07–1.23; p = 0.10) to originate from SCM (Table 1).
Clinical manifestation of mastitis is associated with a large number of different genes. To 
study genetic differences that could underlay variation in pathogenity of bovine S. aureus isolates, we performed 
a genome wide association study (GWAS) and 153 genes were associated with CM isolates. In agreement with 
the results from the GLMM, genes exclusively present in the CC479 isolates (n = 59) had the highest OR, rang-
ing from 4.6 to 5.6 [Benjamini–Hochberg Procedure (BHP); p-values < 0.05]. Among the CM-associated genes, 
a total of 20 genes matched our inclusion criteria for significant genes of interest (best pairwise comparision 
p < 0.1; BHP p < 0.1) and the OR of these genes ranged from 1.95 to 3.42 (Table 3). Among these genes, the 
hypothetical potentially bacteriophage derived DUF3310 domain-containing protein (OR 2.35) was the only 
gene associated with CM that was detected among all main lineages. Carriage of SA genes seM, seN, seI, seG, seO 
Table 3.  Odds Ratio, carriage rate per clonal complex and GenBank references of genes associated with 
clinical mastitis based on a genome wide association study performed on 276 S. aureus isolates obtained from 
bovine clinical and subclinical mastitis in 11 European countries. a Gene annotation by prokka and confirmed 
using BLAST search of gene sequence 4. Carriage rate of gene per clonal complex. b Odds Ratio of causing 
clinical rather than subclinical mastitis from the Genome wide association study 5. Includes isolates belonging 
to CC9, CC50, CC5, CC49, CC7, CC45, CC101, CC20, CC30 and CC425. c Best pairwise comparison P value 
from GWAS performed using scoary.
Genea
Odds 
 Ratiob
Best pairwise 
comparision 
 pc
CC151 
(%)d
CC97 
(%)
CC479 
(%)
CC133 
(%)
CC398 
(%) CC1 (%)
CC20 
(%) CC8 (%)
Other 
CCs 
(%)5
Weighted 
average 
(%)
GenBank 
reference
DUF3310 domain-
containing protein 2.35 < 0.001 82 60 97 74 95 79 80 30 50 75 WP_001624706.1
DUF2483 domain-
containing phage 
protein
2.36 0.01 43 35 97 12 0 7 0 11 10 33 WP_001077279.1
NAD-specific 
glutamate dehydro-
genase
2.83 0.01 100 0 97 60 0 0 0 0 30 50 SAO39934.1
phiPVL ORF050-
like protein 2.23 0.02 98 77 100 0 0 14 30 0 17 59 ABD21348.1
Staphylococcal 
enterotoxin type 
C1/U
2.21 0.03 98 0 100 0 0 0 0 0 66 44 WP_109162118.1
Staphylococcal 
enterotoxin type G 1.95 0.04 98 0 100 0 0 0 100 0 43 49 WP_141060424.1
Staphylococcal 
enterotoxin type N 1.95 0.04 98 0 100 0 0 0 100 0 43 49 WP_109162119.1
Staphylococcal 
enterotoxin type I 1.95 0.04 98 0 100 0 0 0 100 0 43 49 QCW39073.1
Multidrug trans-
porter protein 
 (SaPIbov3)
2.31 0.04 99 77 100 0 0 14 30 0 17 59 WP_065315972.1
Intramembrane 
metalloprotease/
(SaPIbov3)
2.31 0.04 99 77 100 0 0 14 30 0 17 59 WP_070008570.1
Hypothetical pro-
tein  (SaPIbov3)
2.31 0.04 99 77 100 0 0 14 30 0 17 59 WP_000921697.1
Staphylococcal 
enterotoxin type M 2.07 0.06 98 0 100 0 0 0 0 0 20 43 WP_109162116.1
SAS066 AgrD ( 
type II) 2.52 0.06 98 0 100 0 0 0 0 0 47 46 SCU54394.1
Accessory gene 
regulator protein 
B4 (type II)
2.52 0.06 98 0 100 0 0 0 0 0 47 46 CZQ66246.1
Hypothetical 
protein 2.83 0.06 100 13 100 0 0 0 0 0 3 44 WP_000389772.1
TfoX/Sxy family 
protein 2.83 0.06 100 13 100 0 0 0 0 0 3 44 WP_000179903.1
Arsenate reductase 1.97 0.06 99 0 100 100 0 0 0 100 66 61 WP_000163240.1
Trypsin-like serine 
protease 2.61 0.06 0 0 100 0 0 0 0 0 50 17 WP_043054986.1
SACOL0901 path-
ogenicity island 
protein
2.82 0.07 98 88 100 84 0 14 30 28 27 71 WP_109183239.1
DUF1433 domain-
containing protein 3.42 0.07 98 98 100 100 0 0 100 0 63 79 WP_031900638.1
7Vol.:(0123456789)
Scientific Reports |        (2020) 10:18172  | https://doi.org/10.1038/s41598-020-75179-2
www.nature.com/scientificreports/
and seU, as well as the accessory gene regulator (agr) D type II gene was associated with CM and these genes 
were present in all CC479 isolates and the majority of CC151 isolates (Table 3). In addition, three genes from 
within the S. aureus pathogenicity island bovine 3  (SaPIbov3) were also associated with CM and were carried by 
all CC151, CC479 and 77% of CC97 isolates.
Furthermore, 61 genes were associated with SCM (i.e. an OR < 1), from which 10 genes matched our selection 
criteria and the OR of these genes ranged between 0.09 and 0.44 (Table 4). Most genes (8/10) coded for hypotheti-
cal proteins and the genes with predicted function were identified as an antitoxin YezG family protein (OR 0.32) 
and a putative DNA binding protein (OR 0.29). The SCM-associated genes were mostly carried by CC1, CC20, 
and CC8 S. aureus, but were always absent from CC479 and most CC151 isolates (Table 4).
Discussion
There is a large diversity in the carriage of virulence and AMR genes between bovine S. aureus  lineages6,9, but 
it is unclear which genetic differences underly the observed variation in pathogenicity following bovine IMI. 
Therefore, this study aimed to identify genetic differences between S. aureus isolated from CM and SCM in 
dairy cattle. A secondary goal of the study was to describe the diversity of bovine S. aureus lineages in Europe 
and their carriage of immune evasion factors. We found CC479 to be strongly associated with CM rather than 
with SCM cases.
Although eighteen different CCs were present in our isolate collection, most S. aureus belonged to a limited 
number of CCs, with the five CCs (CC151, CC97, CC479, CC133 and CC398) making up more than 75% of all 
isolates. All these CCs have previously been associated with bovine  mastitis6,19,27,28. The distribution of S. aureus 
CCs differed between geographical locations. Although the isolates in our collection were not a random sample, 
they did originate from 254 unique herds with a maximum of one CM and one SCM isolate from the same herd. 
The prevalence of S. aureus CCs per country from our study is in line with studies performed in  Denmark29, 
 Germany6 and The  Netherlands30. Nevertheless, these isolates cannot be expected to fully represent the genetic 
diversity of bovine S. aureus on a national level. Because in addition to a relative low number of isolates, there 
likely was some clustering within certain regions in several of the countries, which may have resulted in an 
underestimation of the true genetic diversity in the population. We must also note that the aim of our sampling 
Table 4.  Odds Ratio, carriage rate per clonal complex and GenBank references of genes associated with 
subclinical mastitis based on a genome wide association study performed on 276 S. aureus isolates obtained 
from bovine clinical and subclinical mastitis in 11 European countries. a Gene annotation by prokka and 
confirmed using BLAST search of gene sequence. b Odds Ratio of causing clinical rather than subclinical 
mastitis from the Genome wide association study. c Best pairwise comparison P value from GWAS performed 
using scoary. d Carriage rate of gene per clonal complex. e Includes isolates belonging to CC9, CC50, CC5, 
CC49, CC7, CC45, CC101, CC20, CC30 and CC425.
Genea
Odds 
 ratiob
Best pairwise 
comparision 
 pc
CC151 
(%)d CC97 (%)
CC479 
(%)
CC133 
(%)
CC398 
(%) CC1 (%) CC20 (%) CC8 (%)
Other 
CCs (%)e
Weighted 
average 
(%)
GenBank 
reference
Putative 
DNA-
binding 
protein
0.29 < 0.01 2 22 0 16 42 64 82 18 7 18 AUM57693.1
Hypo-
thetical 
protein
0.40 < 0.01 0 94 0 0 100 100 100 100 34 42 WP_000375476.1
Hypo-
thetical 
protein
0.27 0.02 0 0 0 0 100 100 100 100 34 24 WP_000070812.1
Probable 
antitoxin 
YezG
0.32 0.03 0 0 0 100 0 0 100 0 3 15 WP_000142094.1
Hypo-
thetical 
protein
0.38 0.03 0 0 0 0 100 100 100 100 62 27 WP_078068548.1
Hypo-
thetical 
protein
0.44 0.03 0 98 0 0 0 100 100 100 62 39 WP_072426418.1
Hypo-
thetical 
protein
0.32 0.04 0 50 0 0 100 7 0 91 52 26 WP_000431307.1
Hypo-
thetical 
protein
0.09 0.06 0 0 0 8 32 0 0 9 14 5 WP_000993183.1
Hypo-
thetical 
protein
0.26 0.06 0 0 0 0 0 100 0 100 34 13 ETO57257.1
Hypo-
thetical 
protein
0.43 0.06 1 0 0 100 100 100 100 100 86 39 WP_078370397.1
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design was to collect isolates from an equal number of clinical and subclinical cases. This does not reflect the true 
population of S. aureus isolates in dairy herds, as the prevalence of subclinical infections is substantially higher 
than of clinical infections. Since CM and SCM are both expressions of S. aureus IMI and as SCM can develop 
into CM and vice  versa31, isolates may have been misclassified, biasing any associations between CM versus SCM 
and S. aureus genotype towards the null-effect. Still, our study, as well as other studies using a similar classifica-
tion of  mastitis20,21, did identify genetic differences between CM and SCM S. aureus isolates, but possibly, some 
other associations may have been missed in our approach.
A key finding of the current study was the association between S. aureus belonging to CC479 and CM. This 
corresponds with a previous study which reported that experimental infection with CC479 S. aureus results in 
more severe clinical signs and a higher bacterial load than infection with a CC151 S. aureus  strain32. In addition, 
the association between CC479 and CM was also observed in our previous analysis of Dutch mastitis  isolates20. 
The underlaying mechanisms for this apparent increased virulence of CC479 remains unknown, but we have 
suggested a SNP in the repressor of toxins (rot) gene, resulting in an increased production of LukMF’ by CC479 
isolates as a possible  cause20. Our GWAS identified several genes associated with clinical outcome of IMI, but 
as S. aureus belonging to the same CC share a similar (virulence) gene profile, there was a strong link between 
carriage of these genes and lineage. Therefore, it was not possible to differentiate between the effect of individual 
genes/sets of genes and S. aureus lineage on the clinical outcome of IMI. Interestingly, genes associated with CM 
by GWAS which were all present in CC479 isolates, were also almost all present in CC151 S. aureus (Table 3), 
whereas the latter CC had an approximately even distribution of isolates originating from CM (51%) and SCM 
(49%). Since CC151 and CC479 share most CM-associated genes, these genes are likely spuriously associated to 
CM, due to confounding by other factors within CC479. Differences in gene expression are more likely causes 
of the increased virulence of CC479, in line with our hypothesis regarding the non-functional rot  gene18. We 
confirmed that this mutation was present in all CC479 isolates within our collection (results not shown). It is 
likely that the absence of functional rot affects the expression levels of multiple virulence genes within CC479 
S. aureus20, likely leading to substantially increased probability of causing CM. Future research, e.g. infection 
studies with genetically modified CC479 isolates lacking potential virulence factors or with restored rot function, 
are required to identify these potential causal mechanisms.
The results from our GLMM suggest that CC8 and CC1 are less likely to cause CM in cows and most of the 
genes that were associated with CM were carried by CC8 and CC1 isolates. Previous work identified that CC8 
predominantly make up the S. aureus genotype B, a highly contagious subtype of S. aureus28,33. We only detected 
CC8 S. aureus among isolates from Italy and Germany, suggesting that this lineage is not widespread through-
out Europe. Indeed, reports on CC8/GTB S. aureus primarily originate from Switzerland and  Austria28,34,35. In 
contrast, the CC1 lineage was detected in six different countries in this study, although 50% of the CC1 isolates 
were collected in Poland.
Phylogenetic trees constructed based on core genome alignment and binary presence and absence of acces-
sory genes clustered the isolates perfectly within the assigned CC. This demonstrates that MLST is an adequate 
genotyping technique, but Fig. 2 shows that considerable variation exists in the accessory genome among isolates 
within a CC. Interestingly, there was very limited variation in accessory gene carriage among CC479 and CC133 
S. aureus isolates and this suggests a rapid clonal expansion of these specific S. aureus clones. The CC133 line-
age is considered a ruminant-adapted lineage but is mostly associated with small  ruminants16. Therefore, it is 
possible that the highly similar bovine CC133 S. aureus isolates represent a subgroup of CC133 S. aureus that is 
adapted to cattle and this subgroup, as well as the highly similar CC479 isolates, is considerably more successful 
at infecting the bovine mammary gland than other CC133, CC479 S. aureus.
Although our analyses showed associations between specific genes and CC with CM, it is important to note 
that none of these genes were essential for CM in our collection. Clones that were associated with CM cases 
based on CC or gene carriage were also cultured from SCM and vice versa. Besides pathogen factors, the clini-
cal outcome of an IMI depends on host factors, such as breed, stage of lactation, environmental factors and 
their  interaction31,36. Nevertheless, from a diagnostic perspective, the identification of S. aureus isolates with an 
increased risk of developing into CM (e.g. CC479) or highly contagious isolates (e.g. CC8) can support farmers 
and veterinarians in deciding on the most appropriate intervention strategy to control S. aureus in a herd. For 
Streptococcus uberis, it has been demonstrated that MALDI-TOF MS performed on milk samples can identify S. 
uberis isolates with increased CM  risk37. However, it is not certain if this technique is able to distinguish between 
different CCs of S. aureus. There are several PCR based test that detect pathogen-specific genes in milk and an 
assay for the detection of CC8 (genotype B) S. aureus has already been  developed44. We identified multiple CC-
specific genes that could be employed to differentiate between common ruminant-associated S. aureus lineages 
(Supplementary Table S1).
In summary, this study identified that a limited number of S. aureus CCs are responsible for bovine masti-
tis in Europe and that CC479 is strongly associated with CM. Although our analysis shows specific genes are 
associated with CM, the presence of these genes in CC associated with SCM indicates it is likely that differential 
gene expression rather than gene carriage affects clinical presentation of IMI. This study shows that the type of 
infecting S. aureus influences the clinical outcome of IMI in dairy cattle. Therefore, identification of S. aureus 
CC can help predict the likelihood of the occurrence of CM following S. aureus IMI and highlights the potential 
benefit of diagnostics tools to identify S. aureus CC during bovine mastitis.
Methods
Bovine mastitis isolates. Twelve mastitis research groups or diagnostic labs from eleven countries (Bel-
gium, Denmark, France, Germany, Hungary, Italy, Poland, Portugal, Spain, The Netherlands and United King-
dom) were asked to submit a convenience sample of approximately 30 S. aureus isolates obtained from cases of 
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bovine mastitis. Participants were asked to submit a maximum of one CM and one SCM isolate per herd with as 
much as possible an equal number of CM and SCM isolates, coming from different regions in their country. The 
sample size was based on what was considered feasible to be collected within a reasonable period of time, while 
giving a good impression on the situation in a country. No formal sample size calculations were performed. For 
each isolate the sampling date, farm ID, geographical location of farm (city and/or region), cow ID, clinical man-
ifestation (CM/SCM) was reported in a pre-structured Excel workbook (Microsoft Corp., Redmond, WA, USA).
Clinical mastitis was defined as visible signs of inflammation of the udder, indicated by a hard swollen quar-
ter and/or abnormal milk; SCM was defined as a high somatic cell count (> 200,000 cells/mL) while no clinical 
signs of mastitis could be observed.. The definitions were communicated to all participating researchers and 
were stated in a workbook to ensure that a uniform definition of CM and SCM was applied by all participants. 
No constraints were put on duration or chronicity of infections. The clinical status (CM or SCM) was observed 
and recorded at the moment of sampling.
Isolates were recultured from their transport media onto to sheep blood agar plates, and incubated overnight 
at 37 °C. Next, single colonies were picked and grown in 2 mL Todd Hewitt Broth (THB) (Sigma, St. Louis, MO, 
USA) for 16 h at 37 °C with agitation. Bacterial glycerol stocks (25% glycerol) were made by adding 0.5 mL of 
bacterial broth to 0.5 mL 50% glycerol solution in distilled water. Furthermore, DNA was extracted using a sim-
ple boiling protocol to confirm bacterial species by PCR targeting the S. aureus specific femA gene, as described 
by Hoekstra et al.20. Isolates that were negative for the femA PCR or lacked mandatory metadata were excluded 
from the final collection. For each herd, a maximum of one isolate from a CM case and one from a SCM case 
was allowed and if multiple CM or SCM isolates were donated from the same herd, one was selected using the 
random number function of Excel 2015 (Microsoft, Redmond, WA, USA).
DNA extraction, genome sequencing and multilocus sequence typing. DNA for whole genome 
sequencing was extracted using the DNeasy UltraClean Microbial Kit (Qiagen, Venlo, The Netherlands) accord-
ing to the manufacturer’s instructions. Purity and DNA yield were measured by spectrophotometry and whole-
genome sequencing was performed using Illumina HiSeq sequencing (Illumina Inc., San Diego, CA, United 
States). Multilocus sequence type was determined based on genome data. Each sequence type was assignment to 
a CC based on eBURST analysis using PHYLOViZ  Online38.
Annotation of genomes, pan‑genome analysis and phylogenetic analyses. After quality control 
of whole genome sequence results, genomes were annotated using prokka v1.1126 and the pan/core genome 
(genes present in 99% < of genomes) determined using roary v3.1239. Alignment of the core genome was per-
formed using MAFFT v7.407 and the phylogenetic trees was built with Fasttree v2.140. Subsequently, trees were 
visualized using iTOL v3.641 and trees were rooted using the CC22 clade. The large-scale BLAST score ratio (LS-
BSR) pipeline was used to obtain matrixes with BLAST score ratio of each annotated  gene25. For each isolate, 
the presence of the genes encoding leukocidin LukMF’ (lukM, GenBank accession: 1262967; lukF′, GenBank 
accession: 1262954), ruminant-specific Staphylococcal complement inhibitor variant (scn, Genbank accession: 
ADN53656.1), SaPI encoded ruminant specific vWFbp variant (SaPI vWFbp, GenBank accession: HM234507.1), 
enterotoxin type I (seI, GenBank accession: EFC00985.1), enterotoxin L (seL, GenBank accession: BAO65763.1), 
toxic shock syndrome toxin 1 (tsst-1, GenBank accession: WP_001035596.1), penicillin-hydrolyzing class A 
beta-lactamase (blaZ, GenBank accession: WP_000733621.1), tetracycline resistance protein type M (tetM, Gen-
Bank accession: AKI94996.1) and penicillin binding protein 2A (mecA, GenBank accession: WP_104447100.1) 
was determined using LS-BSR output. Genes were identified using a threshold value of BSR of > 0.9 compared to 
the reference gene. In addition, a heatmap of LS-BSR score of isolates was created for genes annotated as SLL or 
SA by prokka26 using the pheatmap  package42 of the R statistical software version v3.5.443.
Statistical analysis. The GLMM analysis was performed using the lme4  package44 of the R statistical soft-
ware version v3.5.443. The model used clinical manifestation of mastitis (SCM, CM) as outcome variable and 
CC of S. aureus was a fixed effect. The country of origin of isolates was used as a random effect in the model. To 
reduce the number of levels within the variable CC, CCs represented by < 10 isolates were grouped together into 
a category ‘Other’. Furthermore, the association between CC and country of origin of mastitis isolates was inves-
tigated by Fisher’s exact test and association between genetic cluster and clinical manifestation was investigated 
using the Pearson’s Chi-squared test. Both tests were performed using the R statistical software version v3.5.443.
GWAS. Based on the pangenome analysis in roary, GWAS was performed using scoary v1.6.1645. Default set-
tings of scoary were used during our analysis with an initial threshold of naive p < 0.01. Genes that matched our 
inclusion criteria (BHP p < 0.1; best pairwise comparison p value of p < 0.1) were considered significant results 
of interest.
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